CNXT 📈 VanEck ChiNext - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US92189F6271 • China Region
CNXT: Chinese, Technology, Internet, Financial, Consumer, Healthcare
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is a free-float adjusted index intended to track the performance of the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The index is comprised of China A-shares ('A-shares'). ‣ Company URL: http://www.vaneck.com ‣ Domicile: United States
Additional Sources for CNXT ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNXT ETF Overview
| Market Cap in USD | 37m |
| Category | China Region |
| TER | 0.65% |
| IPO / Inception | 2014-07-23 |
CNXT ETF Ratings
| Growth 5y | -10.5% |
| Fundamental | - |
| Dividend | 0.12% |
| Rel. Strength Industry | -20.4 |
| Analysts | - |
| Fair Price Momentum | 27.13 USD |
| Fair Price DCF | - |
CNXT Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 0.4% |
CNXT Growth Ratios
| Growth Correlation 3m | -23.2% |
| Growth Correlation 12m | 33.9% |
| Growth Correlation 5y | -59.7% |
| CAGR 5y | 1.30% |
| CAGR/Mean DD 5y | 0.04 |
| Sharpe Ratio 12m | 0.56 |
| Alpha | 5.54 |
| Beta | 0.53 |
| Volatility | 48.67% |
| Current Volume | 13.9k |
| Average Volume 20d | 27.7k |
What is the price of CNXT stocks?
As of December 27, 2024, the stock is trading at USD 28.57 with a total of 13,887 shares traded.
Over the past week, the price has changed by +1.27%, over one month by +0.51%, over three months by +31.22% and over the past year by +22.32%.
As of December 27, 2024, the stock is trading at USD 28.57 with a total of 13,887 shares traded.
Over the past week, the price has changed by +1.27%, over one month by +0.51%, over three months by +31.22% and over the past year by +22.32%.
Is VanEck ChiNext a good stock to buy?
Neither. Based on ValueRay Analyses, VanEck ChiNext is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -10.45 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNXT as of December 2024 is 27.13. This means that CNXT is currently overvalued and has a potential downside of -5.04%.
Neither. Based on ValueRay Analyses, VanEck ChiNext is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -10.45 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNXT as of December 2024 is 27.13. This means that CNXT is currently overvalued and has a potential downside of -5.04%.
Is CNXT a buy, sell or hold?
VanEck ChiNext has no consensus analysts rating.
VanEck ChiNext has no consensus analysts rating.
What are the forecast for CNXT stock price target?
According to ValueRays Forecast Model, CNXT VanEck ChiNext will be worth about 29.7 in December 2025. The stock is currently trading at 28.57. This means that the stock has a potential upside of +4.03%.
According to ValueRays Forecast Model, CNXT VanEck ChiNext will be worth about 29.7 in December 2025. The stock is currently trading at 28.57. This means that the stock has a potential upside of +4.03%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 29.7 | 4% |